AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 1,079 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,079 |
| Operating Expenses | 24,762 | 22,098 | 20,515 | 19,069 | 22,143 |
| Operating Income | -24,762 | -22,098 | -20,515 | -19,069 | -21,065 |
| Interest Expense | 188 | 197 | 222 | 29 | -542 |
| Other Income | 1,861 | 4,953 | -195 | 600 | -588 |
| Pre-tax Income | -23,089 | -17,343 | -20,932 | -18,498 | -21,111 |
| Net Income Continuous | -23,093 | -17,343 | -20,932 | -18,498 | -21,111 |
| Net Income | $-23,093 | $-17,343 | $-20,932 | $-18,498 | $-21,111 |
| EPS Basic Total Ops | -0.28 | -0.24 | -0.29 | -0.25 | -0.30 |
| EPS Basic Continuous Ops | -0.28 | -0.24 | -0.29 | -0.26 | -0.29 |
| EPS Diluted Total Ops | -0.28 | -0.24 | -0.29 | -0.25 | -0.30 |
| EPS Diluted Continuous Ops | -0.28 | -0.24 | -0.29 | -0.26 | -0.29 |
| EBITDA(a) | $-24,067 | $-21,414 | $-19,868 | $-18,464 | $-20,543 |